Nuvectis Pharma, Inc.
Support and Resistance Levels
Past performance
News About NVCT
All events for NVCT
All deals for NVCT
Financial Ratios
Financial Statements
NVCT vs Sector & Peers
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020. Website nuvectis.com
Headquarters Fort Lee, NJ, US